• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    More On GENE

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Genetic Technologies Limited (GENE)

    -NasdaqCM
    2.30 Up 0.16(7.48%) Aug 28, 3:59PM EDT
    Add to Portfolio
    Prev Close:2.14
    Open:2.19
    Bid:1.00 x 200
    Ask:2.36 x 100
    1y Target Est:12.50
    Beta:2.1
    Next Earnings Date:N/A
    Day's Range:2.15 - 2.30
    52wk Range:1.04 - 11.00
    Volume:294,981
    Avg Vol (3m):450,252
    Market Cap:13.01M
    P/E (ttm):N/A
    EPS (ttm):-1.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GENE

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of genetic tests for breast and ovarian cancer, bowel and uterine cancer, and prostate cancer; neurogenetic diagnostic a... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback